Pulmoner arteriyovenöz malformasyonlar (PAVM), sağ-sol şanta neden olabilen pulmoner arter ile pulmoner venler arasındaki anormal direkt bağlantılardır. Bu malformasyonlar en çok herediter hemorajik telenjiektazi hastalığı ile birlikte görülmektedir. Pulmoner anjiyografi altın standart olmakla beraber, akciğer grafisi, kontraslı bilgisayarlı tomografi ve kontrastlı ekokardiyografi kullanılan diğer tanısal araçlardır. Genellikle ilk tercih edilen tedavi şekli PAVM’lerin afferent arterlerinin embolizasyonudur. Embolizasyonun başarısız olduğu durumlarda, embolizasyona rağmen ciddi kanama gelişen hastalarda, PAVM plevraya açıldığında veya tedavi edilemeyen kontrast madde alerjisi olanlarda ve lezyonları embolizasyon için uygun olmayanlarda PAVM’nin cerrahi rezeksiyon endikasyonu vardır.
Pulmonary arteriovenous malformations (PAVMs) are abnormal direct connections between the pulmonary artery and pulmonary vein which may result in a rightto- left shunt. Theses malformations mostly present with hereditary hemorrhagic telangiectasia disease. Although pulmonary angiography is the gold standard, chest radiography, contrast enhanced computed tomography and contrast echocardiography are among other diagnostic tools. The initial treatment of choice is usually embolization of the afferent arteries to the PAVMs. Surgical resection of PAVMs is indicated for the patients in whom embolization fails and who develop serious bleeding complication despite embolization and have intrapleural rupture of the PAVM, or untreatable contrast agent allergy and lesions not amenable to embolization. ">
[PDF] Pulmoner arteriyovenöz malformasyonlar | [PDF] Pulmonary arteriovenous malformations
Pulmoner arteriyovenöz malformasyonlar (PAVM), sağ-sol şanta neden olabilen pulmoner arter ile pulmoner venler arasındaki anormal direkt bağlantılardır. Bu malformasyonlar en çok herediter hemorajik telenjiektazi hastalığı ile birlikte görülmektedir. Pulmoner anjiyografi altın standart olmakla beraber, akciğer grafisi, kontraslı bilgisayarlı tomografi ve kontrastlı ekokardiyografi kullanılan diğer tanısal araçlardır. Genellikle ilk tercih edilen tedavi şekli PAVM’lerin afferent arterlerinin embolizasyonudur. Embolizasyonun başarısız olduğu durumlarda, embolizasyona rağmen ciddi kanama gelişen hastalarda, PAVM plevraya açıldığında veya tedavi edilemeyen kontrast madde alerjisi olanlarda ve lezyonları embolizasyon için uygun olmayanlarda PAVM’nin cerrahi rezeksiyon endikasyonu vardır. ">
Pulmoner arteriyovenöz malformasyonlar (PAVM), sağ-sol şanta neden olabilen pulmoner arter ile pulmoner venler arasındaki anormal direkt bağlantılardır. Bu malformasyonlar en çok herediter hemorajik telenjiektazi hastalığı ile birlikte görülmektedir. Pulmoner anjiyografi altın standart olmakla beraber, akciğer grafisi, kontraslı bilgisayarlı tomografi ve kontrastlı ekokardiyografi kullanılan diğer tanısal araçlardır. Genellikle ilk tercih edilen tedavi şekli PAVM’lerin afferent arterlerinin embolizasyonudur. Embolizasyonun başarısız olduğu durumlarda, embolizasyona rağmen ciddi kanama gelişen hastalarda, PAVM plevraya açıldığında veya tedavi edilemeyen kontrast madde alerjisi olanlarda ve lezyonları embolizasyon için uygun olmayanlarda PAVM’nin cerrahi rezeksiyon endikasyonu vardır.
Pulmonary arteriovenous malformations (PAVMs) are abnormal direct connections between the pulmonary artery and pulmonary vein which may result in a rightto- left shunt. Theses malformations mostly present with hereditary hemorrhagic telangiectasia disease. Although pulmonary angiography is the gold standard, chest radiography, contrast enhanced computed tomography and contrast echocardiography are among other diagnostic tools. The initial treatment of choice is usually embolization of the afferent arteries to the PAVMs. Surgical resection of PAVMs is indicated for the patients in whom embolization fails and who develop serious bleeding complication despite embolization and have intrapleural rupture of the PAVM, or untreatable contrast agent allergy and lesions not amenable to embolization. ">
Pulmoner arteriyovenöz malformasyonlar (PAVM), sağ-sol şanta neden olabilen pulmoner arter ile pulmoner venler arasındaki anormal direkt bağlantılardır. Bu malformasyonlar en çok herediter hemorajik telenjiektazi hastalığı ile birlikte görülmektedir. Pulmoner anjiyografi altın standart olmakla beraber, akciğer grafisi, kontraslı bilgisayarlı tomografi ve kontrastlı ekokardiyografi kullanılan diğer tanısal araçlardır. Genellikle ilk tercih edilen tedavi şekli PAVM’lerin afferent arterlerinin embolizasyonudur. Embolizasyonun başarısız olduğu durumlarda, embolizasyona rağmen ciddi kanama gelişen hastalarda, PAVM plevraya açıldığında veya tedavi edilemeyen kontrast madde alerjisi olanlarda ve lezyonları embolizasyon için uygun olmayanlarda PAVM’nin cerrahi rezeksiyon endikasyonu vardır.
Pulmonary arteriovenous malformations
Pulmonary arteriovenous malformations (PAVMs) are abnormal direct connections between the pulmonary artery and pulmonary vein which may result in a rightto- left shunt. Theses malformations mostly present with hereditary hemorrhagic telangiectasia disease. Although pulmonary angiography is the gold standard, chest radiography, contrast enhanced computed tomography and contrast echocardiography are among other diagnostic tools. The initial treatment of choice is usually embolization of the afferent arteries to the PAVMs. Surgical resection of PAVMs is indicated for the patients in whom embolization fails and who develop serious bleeding complication despite embolization and have intrapleural rupture of the PAVM, or untreatable contrast agent allergy and lesions not amenable to embolization.
3. Gossage JR. Pulmonary AVMs, including hereditary hemorrhagic telangiectasia: Etiology and clinical features. Available from: http://www.uptodate.com/contents/ pulmona r y-avms-including-heredita r y-hemor rhagictelangiectasia- etiology-and-clinical-features.
4. Fuchizaki U, Miyamori H, Kitagawa S, Kaneko S, Kobayashi K. Hereditary haemorrhagic telangiectasia (Rendu-Osler- Weber disease). Lancet 2003;362:1490-4.
6. Büyükşirin M, Kararmaz E, Güldaval F, Gümüş B, Yaşar E. Pulmoner arteriovenöz malformasyon: İki olgu nedeniyle. İzmir Göğüs Hstanesi Dergisi 2011;15:57-62.
17. Mahmoud M, Allinson KR, Zhai Z, Oakenfull R, Ghandi P, Adams RH, et al. Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res 2010;106:1425-33.
18. Shovlin CL, Jackson JE. Pulmonary arteriovenous malformations and other pulmonary vascular abnormalities. In: Mason RJ, Broaddus VC, Martin TR, King TE, Schraufnagel DE, Murray JF, et al, editors. Mason: Murray and Nadel’s textbook of respiratory medicine. Vol 1, 5th ed. Philadelphia: Saunders Elsevier; 2010. p. 2963-89.
19. Berg JN, Guttmacher AE, Marchuk DA, Porteous ME. Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 1996;33:256-7.
20. Gossage JR, Kanj G. Pulmonary arteriovenous malformations. A state of the art review. Am J Respir Crit Care Med 1998;158:643-61.
21. Thung KH, Sihoe AD, Wan IY, Lee TW, Wong R, Yim AP. Hemoptysis from an unusual pulmonary arteriovenous malformation. Ann Thorac Surg 2003;76:1730-3.
22. Mager JJ, Westermann CJ. Value of capillary microscopy in the diagnosis of hereditary hemorrhagic telangiectasia. Arch Dermatol 2000;136:732-4.
23. Dines DE, Arms RA, Bernatz PE, Gomes MR. Pulmonary arteriovenous fistulas. Mayo Clin Proc 1974;49:460-5.
24. Elmali M, Akan H, Findik S, Kale M, Celenk C. Hereditary hemorrhagic telangiectasia associated with pulmonary arteriovenous malformations presenting as hemothorax. J Thorac Imaging 2008;23:295-7.
25. Desai AD, Bandi V, Holzhauser L, Loebe M, Noon G, Lunn W. Bleeding after biopsy of bronchial arteriovenous malformation presenting as an endobronchial mass. J Bronchol 2008;15:176-8.
26. Gossage JR. Pulmonary AVMs, including hereditary hemorrhagic telangiectasia: Diagnosis and treatment. Available from: http://www.uptodate.com/contents/ pulmona r y-avms-including-heredita r y-hemor rhagictelangiectasia- diagnosis-and-treatment.
27. Remy J, Remy-Jardin M, Wattinne L, Deffontaines C. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 1992;182:809-16.
28. Khalil A, Farres MT, Mangiapan G, Tassart M, Bigot JM, Carette MF. Pulmonary arteriovenous malformations. Chest 2000;117:1399-403.
29. White RI Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996;7:787-804.
30. Haitjema TJ, Overtoom TT, Westermann CJ, Lammers JW. Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients. Thorax 1995;50:719-23.
31. Cottin V, Plauchu H, Bayle JY, Barthelet M, Revel D, Cordier JF. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 2004;169:994-1000.
32. Gazzaniga P, Buscarini E, Leandro G, Reduzzi L, Grosso M, Pongiglione G, et al. Contrast echocardiography for pulmonary arteriovenous malformations screening: does any bubble matter? Eur J Echocardiogr 2009;10:513-8.
33. Swanson KL, Prakash UB, Stanson AW. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. Mayo Clin Proc 1999;74:671-80.
34. Maher CO, Piepgras DG, Brown RD Jr, Friedman JA, Pollock BE. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001;32:877-82.
35. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011;48:73-87.
36. Pollak Y, Katzen BT, Pollak W. High-output congestive failure in a patient with pulmonary arteriovenous malformations. Cardiol Rev 2002;10:188-92.
37. Puskas JD, Allen MS, Moncure AC, Wain JC Jr, Hilgenberg AD, Wright C, et al. Pulmonary arteriovenous malformations: therapeutic options. Ann Thorac Surg 1993;56:253-7.
38. Taylor BG, Cockerill EM, Manfredi F, Klatte EC. Therapeutic embolization of the pulmonary artery in pulmonary arteriovenous fistula. Am J Med 1978;64:360-5.
39. Ando K, Mochizuki A, Kurimoto N, Yokote K, Nakajima Y, Osada H, et al. Coil embolization for pulmonary arteriovenous malformation as an organ-sparing therapy: outcome of longterm follow-up. Ann Thorac Cardiovasc Surg 2011;17:118-23.
40. Pollak JS, Saluja S, Thabet A, Henderson KJ, Denbow N, White RI Jr. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol 2006;17:35-44.
41. Chilvers ER, Whyte MK, Jackson JE, Allison DJ, Hughes JM. Effect of percutaneous transcatheter embolization on pulmonary function, right-to-left shunt, and arterial oxygenation in patients with pulmonary arteriovenous malformations. Am Rev Respir Dis 1990;142:420-5.
42. Lee DW, White RI Jr, Egglin TK, Pollak JS, Fayad PB, Wirth JA, et al. Embolotherapy of large pulmonary arteriovenous malformations: long-term results. Ann Thorac Surg 1997;64:930-9.
43. Shovlin CL, Tighe HC, Davies RJ, Gibbs JS, Jackson JE. Embolisation of pulmonary arteriovenous malformations: no consistent effect on pulmonary artery pressure. Eur Respir J 2008;32:162-9.
44. Shovlin CL, Jackson JE, Bamford KB, Jenkins IH, Benjamin AR, Ramadan H, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008; 63:259-66.
45. Post MC, Thijs V, Schonewille WJ, Budts W, Snijder RJ, Plokker HW, et al. Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology 2006;66:202-5.
46. Brown SE, Wright PW, Renner JW, Riker JB. Staged bilateral thoracotomies for multiple pulmonary arteriovenous malformations complicating hereditary hemorrhagic telangiectasia. J Thorac Cardiovasc Surg 1982;83:285-9.
47. Minami M, Fujii Y, Mizuta T, Kishima H, Matsuda H. Video-assisted thoracoscopic local excision of pulmonary arteriovenous fistula. J Thorac Cardiovasc Surg 1996;112:1395-7.
48. Faughnan ME, Lui YW, Wirth JA, Pugash RA, Redelmeier DA, Hyland RH, et al. Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest 2000;117:31-8.